Therapeutic Asset Ratings
603 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Abemaciclib
Renal Cell Carcinoma
Memorial Sloan Kettering Cancer Center
P1/2
CCC
(50)
Atezolizumab
Acute Myeloid Leukemia
Memorial Sloan Kettering Cancer Center
P1/2
CCC
(50)
Ganetespib
HER2 Positive Breast Carcinoma
Memorial Sloan Kettering Cancer Center
P2
CCC
(49)
PROPRANOLOL
Fallopian Tube Cancer
Memorial Sloan Kettering Cancer Center
P1
CCC
(49)
Mirdametinib
MEK1 Gene Mutation
Memorial Sloan Kettering Cancer Center
P1/2
CCC
(49)
Mirdametinib
MEK2 Gene Mutation
Memorial Sloan Kettering Cancer Center
P1/2
CCC
(49)
Revumenib
Leukemia
Memorial Sloan Kettering Cancer Center
P1/2
CCC
(49)
Ratg
Myelodysplastic Syndrome
Memorial Sloan Kettering Cancer Center
P3
CCC
(48)
18F-ASIS
Prostate Cancer
Memorial Sloan Kettering Cancer Center
P2
CCC
(48)
Clindamycin
Glioblastoma
Memorial Sloan Kettering Cancer Center
P2
CCC
(48)
Degarelix
Leukemia
Memorial Sloan Kettering Cancer Center
P2
CCC
(48)
Dostarlimab
Solid Tumor, Adult
Memorial Sloan Kettering Cancer Center
P2
CCC
(48)
E-7820
Myelodysplastic Syndrome
Memorial Sloan Kettering Cancer Center
P2
CCC
(48)
Ensartinib
Melanoma
Memorial Sloan Kettering Cancer Center
P2
CCC
(48)
Epcoritamab
Lymphoma
Memorial Sloan Kettering Cancer Center
P2
CCC
(48)
Etimupepimut
Melanoma
Memorial Sloan Kettering Cancer Center
P2
CCC
(48)
Glipizide
Pancreatic Ductal Adenocarcinoma
Memorial Sloan Kettering Cancer Center
P2
CCC
(48)
LEUPROLIDE
Leukemia
Memorial Sloan Kettering Cancer Center
P2
CCC
(48)
MOGAMULIZUMAB
Lymphoma
Memorial Sloan Kettering Cancer Center
P2
CCC
(48)
Obecabtagene Autoleucel
Acute Lymphoblastic Leukemia
Memorial Sloan Kettering Cancer Center
P2
CCC
(48)
Oleogel-S10
Breast Cancer
Memorial Sloan Kettering Cancer Center
P2
CCC
(48)
Radium Dichloride
Prostate Cancer
Memorial Sloan Kettering Cancer Center
P2
CCC
(48)
Trastuzumab Deruxtecan
Glioblastoma
Memorial Sloan Kettering Cancer Center
P2
CCC
(48)
Trastuzumab Emtansine
Lung Cancer
Memorial Sloan Kettering Cancer Center
P2
CCC
(48)
Triamcinalone
Breast Cancer
Memorial Sloan Kettering Cancer Center
P2
CCC
(48)
Showing 301 to 325 of 603 assets
Previous
Page 13 of 25
Next